Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$12.35 - $19.33 $24 - $38
2 New
2 $0
Q4 2022

Feb 07, 2023

SELL
$25.29 - $35.48 $227 - $319
-9 Reduced 52.94%
8 $0
Q3 2022

Nov 14, 2022

BUY
$24.0 - $33.42 $72 - $100
3 Added 21.43%
17 $0
Q2 2022

Aug 02, 2022

BUY
$24.78 - $33.36 $346 - $467
14 New
14 $0

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.